John Wallbillich IV, MD, Obstetrics & Gynecology, Detroit, MI, Karmanos Cancer Center

JohnJosephWallbillichIVMD

Obstetrics & Gynecology Detroit, MI

Gynecologic Oncology

Assistant Professor, Gynecologic Oncology, Karmanos Cancer Institute

Overview of Dr. Wallbillich

Dr. John Wallbillich is an obstetrician/gynecologist in Detroit, MI and is affiliated with Karmanos Cancer Center. He received his medical degree from University of Michigan Medical School and has been in practice 8 years. He is one of 23 doctors at Karmanos Cancer Center who specialize in Obstetrics & Gynecology.

Education & Training

  • Medical College of Georgia
    Medical College of GeorgiaPost-Doctoral Fellowship, NIH Women’s Reproductive Health Research Scholar, 2016 - 2019
  • Ohio State University College of Medicine
    Ohio State University College of MedicineFellowship, Gynecologic Oncology, 2013 - 2016
  • University of Texas Health Science Center - Houston
    University of Texas Health Science Center - HoustonResidency, Obstetrics and Gynecology, 2009 - 2013
  • University of Michigan Medical School
    University of Michigan Medical SchoolClass of 2009

Certifications & Licensure

  • MI State Medical License
    MI State Medical License 2019 - 2022
  • GA State Medical License
    GA State Medical License 2016 - 2019
  • OH State Medical License
    OH State Medical License 2013 - 2017
  • American Board of Obstetrics and Gynecology Obstetrics & Gynecology

Awards, Honors, & Recognition

  • GCC Superhero Award Georgia Cancer Center at Augusta University, 2019
  • Felix Rutlege Fellowship MD Anderson Cancer Center, 2012
  • James B. Angell Scholar University of Michigan, 2004
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Vinblastine, cisplatin, cyclophosphamide, bleomycin, doxorubicin, and etoposide (VPCBAE) in the management of three patients with small-cell carcinoma of the ovary  
    John J. Wallbillich, Alpa M. Nick, Pedro T. Ramirez, Jack L. Watkins, Elizabeth D. Euscher, Kathleen M. Schmeler, Gynecologic Oncology Case Reports

Abstracts/Posters

  • Clinical Practice Guidelines decrease unnecessary Pap tests in survivors of gynecologic malignancies.
    Meyer L, Schmeler K, Wallbillich J, Urbauer D, Soliman P, Frumovitz M, Burke C, Bodurka D, Levenback C, The Society for Gynecologic Oncology Annual Meeting on Women’s Cancer; Orlando, FL., 3/1/2011
  • Clinical Practice Guidelines decrease unnecessary Pap tests in survivors of gynecologic malignancies.
    Meyer L, Schmeler K, Wallbillich J, Urbauer D, Soliman P, Frumovitz M, Burke C, Bodurka D, Levenback C, Gynecologic Oncology, 1/1/2011
  • The Proper Pap: Reducing the Overutilization of Pap Test for Disease Surveillance in Survivors of Gynecologic Malignancies.
    Meyer L, Levenback C, Wallbillich J, Garcia E, Urbauer D, Soliman P, Frumovitz M, Burke C, Schmeler K, University of Texas System Clinical Safety and Effectiveness Conference; Austin, TX., 11/1/2010
  • Join now to see all

Hospital Affiliations